Haiqing Dong | Nanodrug Formulations | Best Researcher Award

Dr. Haiqing Dong 👩‍🔬 is an Associate Professor at the School of Medicine, Tongji University 🏫, Shanghai 🇨🇳. Her pioneering research focuses on nanodrug formulations and living drug delivery systems for anti-tumor and skin disease therapies 💊🧫. She has developed advanced ROS-clearing nanomedicines to treat psoriasis and prevent relapse 🌿. Recognized with the Third Prize of the Shanghai Science and Technology Award 🏅, Dr. Dong has led multiple national and international research projects 🌍 and published over 20 influential papers, including highly cited hot papers in top-tier journals like Nature Communications and Advanced Science 📚✨.

Publication Profiles

Scopus

 Education & Experience 

🎓 Education:

• 🎓 Ph.D. in Biomedical or Pharmaceutical Sciences

• 🧪 Specialized training in Nanodrug Formulation and Living Drug Delivery Systems

• 📚 Advanced academic and research training at Tongji University, Shanghai, China 🇨🇳

💼 Professional Experience:

• 👩‍🏫 Associate Professor, School of Medicine, Tongji University, Shanghai 🇨🇳
  ▫️ Leads research on tumor microenvironment modulation and skin disease therapy using nanomedicine 🧬💊

• 🧠 Principal Investigator for multiple national and international research projects (NSFC, SNSF, Shanghai Talent Project) 🌍📊

• 📈 Key Achievements include:
  ▫️ Development of ROS-clearing nanoformulations for psoriasis treatment 🌿
  ▫️ Recipient of the Third Prize of the Shanghai Science and Technology Award 🏆
  ▫️ Over 20 peer-reviewed publications, including in Nature Communications and JACS 📰📈

Suitability for the Award

Assist Prof. Dr. Haiqing Dong, an Associate Professor at the School of Medicine, Tongji University, stands out as an exceptional candidate for the Best Researcher Award, thanks to her pioneering work in nanomedicine and innovative drug delivery systems. With a profound commitment to addressing challenging health conditions like cancer and skin diseases, Dr. Dong’s research integrates nanotechnology with biomedical sciences to engineer targeted, effective, and safe treatments. Her robust academic output, impactful grants, and international recognition collectively demonstrate excellence in translational research.

 Professional Development

Dr. Dong’s career reflects excellence in nanomedicine research and translational science 🔬. Her work on ROS-clearing nanoformulations for skin diseases and programmable drug delivery for tumors stands at the forefront of biomedical innovation 💡🧪. She actively secures competitive funding, including grants from the NSFC, SNSF, and Shanghai Talent Project 🎯. With a strong publication record and international collaborations, she mentors emerging researchers and contributes to global health advancement 🌏👩‍🏫. Her leadership and scientific rigor position her as a rising star in bioengineering and nanotechnology 🌟.

 Research Focus 

Dr. Dong’s research is centered on cutting-edge nanotherapeutics for precision medicine 🧬. She develops novel nanodrug formulations to modulate tumor and skin disease microenvironments 🔬🧫. Her studies on living drug delivery systems explore bioresponsive platforms that intelligently release drugs within tumors for enhanced efficacy 💉🧠. Her innovations in ROS-scavenging nanoformulations aim to treat and prevent chronic inflammatory conditions like psoriasis 🌿. By integrating materials science, immunotherapy, and clinical relevance, Dr. Dong’s interdisciplinary approach addresses urgent biomedical challenges with real-world impact 🩺⚙️.

 Awards & Honors 

• 🏆 Third Prize, Shanghai Science and Technology Award

• 🧪 Principal Investigator of 3 NSFC grants

• 🌍 Recipient of 2 SNSF (Swiss National Science Foundation) grants

• 🌟 Awardee, Shanghai Talent Project

• 📄 Over 20 Publications as First or Corresponding Author

• 🔥 2 Highly Cited Hot Papers (ESI-recognized) in Biomaterials Science and Advanced Science

Publication Top Noted

• ❤️ Anti-pyroptosis biomimetic nanoplatform loading puerarin for myocardial infarction repair: From drug discovery to drug delivery – Biomaterials, 2025 📅 | Cited by: 8 🔬

• 🧫 Metagenomic and proteomic insights into graphene oxide-boosted anaerobic co-fermentation of food waste and sewage sludge for volatile fatty acids production – Chemical Engineering Journal, 2025 📅 | Cited by: 1 📖

• 🧬 Novel injectable sodium alginate hydrogel developed for improved endometrial repair with human umbilical cord mesenchymal stem cells – Drug Delivery and Translational Research, 2025 📅 | Cited by: 1 📖

• 🧴 Single-Atom Catalysts with Isolated Cu1-N4 Sites for Atopic Dermatitis Cascade Catalytic Therapy via Activating PPAR Signaling – Small, 2024 📅 | Cited by: 4 🧪

• 🧠 Nano-mechanical Immunoengineering: Nanoparticle Elasticity Reprograms Tumor-Associated Macrophages via Piezo1 – ACS Nano, 2024 📅 | Cited by: 6 📊

• 🧫 NOX2 Enzyme Mimicking Nano-Networks Regulate Tumor-Associated Macrophages to Initiate Both Innate and Adaptive Immune Effects – Advanced Healthcare Materials, 2024 📅 | Cited by: 2 🧠

• 🔬 Erythrocyte-Derived Bioactive Nanovesicles Reverse the Immunosuppressive Function of Adenosine for Tumor Photoimmunotherapy – Advanced Functional Materials, 2024 📅 | Cited by: 3 💡

• ⚗️ Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy – Small, 2024 📅 | Cited by: 24 📚